Back
Concentrix Corp. 10K Form
Sell
1
CNXC
Concentrix Corp.
Last Price:
$30.44
Seasonality Move:
-10.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-06 | 10Q | CNXC/Concentrix Corp. Quarterly |
| 2023-07-07 | 10Q | CNXC/Concentrix Corp. Quarterly |
| 2023-04-07 | 10Q | CNXC/Concentrix Corp. Quarterly |
| 2022-10-07 | 10Q | CNXC/Concentrix Corp. Quarterly |
| 2022-07-08 | 10Q | CNXC/Concentrix Corp. Quarterly |
| 2022-04-08 | 10Q | CNXC/Concentrix Corp. Quarterly |
Receive CNXC News And Ratings
See the #1 stock for the next 7 days that we like better than CNXC
CNXC Financial Statistics
Sales & Book Value
| Annual Sales: | $9.8B |
|---|---|
| Cash Flow: | $281.2M |
| Price / Cash Flow: | 3.35 |
| Annual Sales: | $44.45 |
| Price / Book: | 0.68 |
Profitability
| EPS (TTM): | -20.73030 |
|---|---|
| Net Income (TTM): | $-1.3B |
| Gross Margin: | $2.8B |
| Return on Equity: | -33% |
| Return on Assets: | -10.79% |
Concentrix Corp. Earnings Forecast
Key Concentrix Corp. Financial Ratios
-
The Gross Profit Margin over the past 13 years for CNXC is 28.30%.
-
The Selling, General & Administrative Expenses for CNXC have been equal to 28.76% of Gross Profit Margin.
-
The Net Earning history of CNXC is -13.06% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 5 years.
Concentrix Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Professional Services |
| Sector: | Industrials |
| Current Symbol: | CNXC |
| CUSIP: | 20602D |
| Website: | concentrix.com |
Debt
| Debt-to-Equity Ratio: | 2.02 |
|---|---|
| Current Ratio: | 1.4 |
| Quick Ratio: | 1.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.9 |
|---|---|
| Forward P/E Ratio: | 2.28 |
CNXC Technical Analysis vs Fundamental Analysis
Sell
1
Concentrix Corp. (CNXC)
is a Sell
Is Concentrix Corp. a Buy or a Sell?
-
Concentrix Corp. stock is rated a SellThe current Concentrix Corp. [CNXC] share price is $30.39. The Score for CNXC is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.